Effect of preemptive dezocine before general anesthesia on postoperative analgesia in patients undergoing laparoscopic cholecystectomy: A prospective observational study

Li Zhou, Youchuan Zhang, Haotian Sun, Ruchun Hu, Jin Wang, Guoyong Xu, Li Zhou, Youchuan Zhang, Haotian Sun, Ruchun Hu, Jin Wang, Guoyong Xu

Abstract

Dezocine is proposed as an adjunctive analgesic for postoperative pain control. This randomized, double-blind, controlled study aimed to investigate the effect of preoperative Dezocine therapy on postoperative pain following laparoscopic cholecystectomy as well as the underlying mechanisms.Eighty patients scheduled for laparoscopic cholecystectomy were randomly allocated into 2 groups as follows: patients in Group D received Dezocine 0.15 mg/kg before anesthesia induction and patients in Group S received same volume of saline. The pain intensity, sedation score, sufentanil-based patient-controlled analgesia (PCA) consumption were recorded for 24 hours after surgery. Plasma concentrations of norepinephrine and serotonin were also measured.During the first 24 hours after surgery, the patients in Group D experienced lower pain score assessed by numerical rating scale (NRS) at 3 hours (rest: P = .038; movement: P = .036), 6 hours (rest: P = .038; movement: P = .036), 12 hours (rest: P = .038; movement: P = .036), and 24 hours (rest: P = .038; movement: P = .036). Dezocine also decreased the sedation levels at 5 minutes (P = .031) after arrival at the PACU. Sufentanil-based PCA consumption in Group D was decreased when compared with Group S in the second to fourth phase after surgery (6-12 hours: P = .017; 12-18 hours: P = .003; 18-24 hours: P = .039). Plasma norepinephrine and serotonin concentrations were higher in the Group D at 24 hours after surgery (norepinephrine: P = .009, serotonin: P = .042). In addition, Group D showed less incidence of nausea/vomiting (P = .032) as well as a higher postoperative satisfaction score after surgery (P = .017).In conclusion, preemptive Dezocine administration is suggested to be useful for the management of postoperative pain in short-lasting surgery such as laparoscopic cholecystectomy.

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1
Flowchart showing details of clinical procedures throughout the study.
Figure 2
Figure 2
Postoperative pain intensity and sedation levels. NRS score for pain at rest (A) and on movement (B) was assessed at 1 h (rest: P = .092; movement: P = .594), 3 h (rest: P = .038; movement: P = .036), 6 h (rest: P = .038; movement: P = 0.036), 12 h (rest: P = .038; movement: P = .036), and 24 h (rest: P = .038; movement: P = .036) after surgery in Group S (blue line) and Group D (red line). (C) Sedation levels were assessed using Ramsay scores at 5 min (P = .031), 10 min (P = .932), 15 min (P = .932), 30 min (P = .997), and 60 min (P = .210) after arrival at the PACU. NRS = numerical rating scale, PACU = postanesthetic care unit. P < .05 versus Group S.
Figure 3
Figure 3
Levels of serotonin and norepinephrine in the plasma. Serotonin and norepinephrine levels were increased in Group D than in Group S at 24 h after surgery (Serotonin: P = .042; norepinephrine: P = .009). P < .05, †P < .01 versus Group S.
Figure 4
Figure 4
Postoperative satisfaction score. Patients in Group D had a higher satisfaction score than that in Group S (P = .0079). P < .05 versus Group S.

References

    1. Kandil TS, El Hefnawy E. Shoulder pain following laparoscopic cholecystectomy: factors affecting the incidence and severity. J Laparoendosc Adv Surg Tech A 2010;20:677–82.
    1. Bisgaard T, Kehlet H, Rosenberg J. Pain and convalescence after laparoscopic cholecystectomy. Eur J Surg 2001;167:84–96.
    1. Liu R, Huang XP, Yeliseev A, et al. Novel molecular targets of dezocine and their clinical implications. Anesthesiology 2014;120:714–23.
    1. Wu FX, Pan RR, Yu WF, et al. The anti-nociception effect of dezocine in a rat neuropathic pain model. Transl Perioper Pain Med 2014;1:5–8.
    1. Wang YX, Mao XF, Li TF, et al. Dezocine exhibits antihypersensitivity activities in neuropathy through spinal mu-opioid receptor activation and norepinephrine reuptake inhibition. Sci Rep 2017;7:43137.
    1. Barrett AC, Smith ES, Picker MJ. Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats. Eur J Pharmacol 2002;452:163–73.
    1. Terner JM, Barrett AC, Grossell E, et al. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats. Psychopharmacology (Berl) 2002;163:183–93.
    1. Wu L, Dong YP, Sun L, et al. Low concentration of dezocine in combination with morphine enhance the postoperative analgesia for thoracotomy. J Cardiothorac Vasc Anesth 2015;29:950–4.
    1. Yu F, Zhou J, Xia S, et al. Dezocine prevents postoperative hyperalgesia in patients undergoing open abdominal surgery. Evid Based Complement Alternat Med 2015;2015:946194.
    1. Chapuis-Roux E, Pellissier L, Browet F, et al. How can recovery be enhanced after single-stage laparoscopic management of CBD stones? Endoscopic treatment versus laparoscopic surgery. Dig Liver Dis 2017;49:773–9.
    1. Murphy GS, Szokol JW, Greenberg SB, et al. Preoperative dexamethasone enhances quality of recovery after laparoscopic cholecystectomy: effect on in-hospital and postdischarge recovery outcomes. Anesthesiology 2011;114:882–90.
    1. Kehlet H, Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth 2001;87:62–72.
    1. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618–25.
    1. Movafegh A, Shoeibi G, Ansari M, et al. Naloxone infusion and post-hysterectomy morphine consumption: a double-blind, placebo-controlled study. Acta Anaesthesiol Scand 2012;56:1241–9.
    1. George RB, McKeen DM, Andreou P, et al. A randomized placebo-controlled trial of two doses of pregabalin for postoperative analgesia in patients undergoing abdominal hysterectomy. Can J Anaesth 2014;61:551–7.
    1. Fragen RJ, Caldwell N. Comparison of dezocine (WY 16, 225) and meperidine as postoperative analgesics. Anesth Analg 1978;57:563–6.
    1. Gharagozlou P, Hashemi E, DeLorey TM, et al. Pharmacological profiles of opioid ligands at kappa opioid receptors. BMC Pharmacol 2006;6:3.
    1. Gal TJ, DiFazio CA. Ventilatory and analgesic effects of dezocine in humans. Anesthesiology 1984;61:716–22.
    1. Downing JW, Brock-Utne JG, Barclay A, et al. WY 16225 (dezocine), a new synthetic opiate agonist-antagonist and potent analgesic: comparison with morphine for relief of pain after lower abdominal surgery. Br J Anaesth 1981;53:59–64.
    1. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008;24:479–96.
    1. Marks DM, Shah MJ, Patkar AA, et al. Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol 2009;7:331–6.
    1. Feng C, Feng M, Jiao R, et al. Effect of Dezocine on IL-12 and IL-10 secretion and lymphocyte activation by culturing dendritic cells from human umbilical cord blood. Eur J Pharmacol 2017;796:110–4.
    1. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain 2011;152:2399–404.

Source: PubMed

3
Sottoscrivi